1.
Winqvist M, Asklid A, Andersson P, Karlsson K, Karlsson C, Lauri B, Lundin J, Mattsson M, Norin S, Sandstedt A, Hansson L, Österborg A. Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group. Haematologica [Internet]. 2016Nov.30 [cited 2026Nov.18];101(12):1573-80. Available from: https://haematologica.org/article/view/7914